Garuda Therapeutics
Developing off-the-shelf hematopoietic stem cell (HSC) therapies to treat a broad range of severe and life-threatening diseases. Learn more
Launch date
Employees
Market cap
-
Enterprise valuation
€327m (Public information from Feb 2023)
Natick Massachusetts (HQ)
Authorizing premium user...